article thumbnail

Leading pharmaceutical wholesalers

Pharmaceutical Technology

Pharmaceutical Technology has listed some of the leading wholesalers of pharmaceutical products based on its intel, insights, and decades of experience in the sector. The post Leading pharmaceutical wholesalers appeared first on Pharmaceutical Technology. GDP and GMP advisory. Temperature control facilities and supply solutions.

Leads 52
article thumbnail

Leading retail pharmacies in pharma

Pharmaceutical Technology

Increasing diagnosis of chronic diseases is expected to lead to fast growth in retail pharmacies. Prescription refill and generic drug programmes. Prescription collection lockers. The post Leading retail pharmacies in pharma appeared first on Pharmaceutical Technology. Speciality care. Compounding services.

Retail 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Ipsen concludes purchase of Albireo Pharma

Pharmaceutical Technology

Albireo’s pipeline includes its lead asset, Bylvay (odevixibat), a potent, once-a-day, oral, non-systemic, ileal bile acid transport inhibitor (IBATi). The regulator issued 15 June this year as a Prescription Drug User Fee Act (PDUFA) action date.

Pharma 52
article thumbnail

News release: Clarify Health unlocks greater clinical trial diversity with launch of Clarify Trials

Clarify Health

Clarify Trials’ analytics draws upon a dataset that includes patient-level SDoH data across an extensive set of factors, such as gender, race, ethnicity, income level, transportation access, housing stability, education level and health literacy. To learn more about Clarify Trials, visit [link].

article thumbnail

Addressing the Polypharmacy Problem

PM360

If one of those conditions is type 2 diabetes, that person may be taking seven prescription medications, 1 managing two or more additional chronic conditions, 2 and paying $13,000 per year on healthcare. senior adults (aged 65+) 7 taking five or more prescription medications. 3 They are also 2.6 In the U.S., 5 This links to 22% of U.S.

article thumbnail

Two Key Questions About Adherence/Compliance in 2023

PM360

Jay Patel From our experience in patient research across many different treatments, we’ve defined several key insights on what may lead to nonadherence: Complex medication routines and patients feeling overwhelmed with their regimen. What if the industry were to incentivize persistence over new prescriptions?

Medical 98
article thumbnail

Breaking through the forecasting fog – 3 trends that will impact critical medicine supply in 2023

pharmaphorum

Transport costs are also likely to remain disproportionately high, driven partly by energy prices, but also by continuing shortages of staff and capacity in the wake of the most acute phase of the Covid-19 pandemic. One prediction is that we will see more tentative moves in this direction.